angiogenesis : Related Words Words similar in meaning to angiogenesis
- angiogenesis«
- endothelial cell«
- maturation«
- vegf«
- growth«
- development«
- blood vessel«
- ontogeny«
- tumor«
- growing«
- capillary«
- ontogenesis«
- cell«
- therapy«
- angiogenic therapy«
- growth factor«
- protein«
- angiogenic growth factor«
- intracoronary administration«
- sema3s«
- receptor«
- cancer cell«
- gene-«
- vessel«
- angiogenic response«
- angiogenic protein«
- protein therapy«
- semaphorins«
- blood vessel growth«
- tumor cell«
- proliferation«
- nutrient«
- intussusception«
- increase«
- disease«
- spect«
- vascular endothelial growth factor«
- waste pathway«
- angiogenic method«
- angiogenesis therapy«
- ad5fgf-4«
- inhibition«
- placebo effect«
- patient«
- mature blood vessel«
- ang2«
- muscle contraction«
- tie-2«
- tie-1«
- angiogenesis research«
- arteriogenesis«
- blood supply«
- formation«
- fgf family«
- local expansion«
- genomic stability«
- tissue«
- myocardial perfusion«
- exercise performance«
- endurance exercise«
- retina«
- cardiovascular disease«
- capillary wall«
- vasculogenesis«
- ongoing clinical trial«
- gene«
- angiogenesis inhibitor«
- major contributor«
- avastin«
- failure«
- tube structure«
- pericytes«
- treatment«
- granulation tissue«
- network«
- trial«
- differentiation«
- clinical testing«
- fibroblast growth factor«
- aerobic exercise«
- tyrosine kinase«
- therapeutic agent«
- smooth muscle cell«
- vasculature«
- solid tumor«
- wound healing«
- upregulation«
- vitro study«
- physiological process«
- macular degeneration«
- fibroblast«
- factor«
- extracellular matrix«
- oxygen«
- sprout«
- human heart«
- malignancy«
- protease«
- metastasis«
- lumen«
- cell type«
- clinical study«
- animal model«
- ligand«
- core«
- significant improvement«
- transition«
- cancer«
- wrong molecular target«
- waste disposal pathway«
- vessel formation process«
- vegf. upregulation«
- vegf receptor-2«
- vegf enzyme pkg.«
- vasculature parameter«
- unwanted angiogenesis«
- unstable tumor cell compartment«
- undesired immune response«
- underperfused tissue«
- tumour reduction«
- tumor vascular structure«
- tumor blood vessels«
- trial inconclusive«
- treadmill exercise test readout«
- transmembrane ligand«
- synthetic angiogenesis inhibitor«
- supportive endpoint«
- suitable treatment choice«
- such localized administration«
- stimulation angiogenesis«
- stable endothelial cell compartment«
- safe therapy«
- reversible myocardial ischemia«
- retinal fluid leak«
- redesigned clinical protocol«
- receptor production«
- recent fgf-1 study«
- protein administration«
- proliferation/survival«
- preferential staining«
- preclinical readout«
- poor vascularisation«
- option heart patient«
- new blood vessel formation«
- neuropilin receptor«
- modern clinical application«
- mitogenic activity critical«
- microvascular density«
- mesoderm cell precursor«
- maximum oxygen delivery«
- maximum nutrient delivery efficiency«
- matrix dissolution«
- massive signaling cascade«
- ischemic chronic wound«
- intussusceptive angiogenesis«
- intracoronary infusion«
- intracoronary delivery«
- insufficient blood vessel formation«
- icams/vcams/mmps«
- human fgf-1«
- heparin proteoglycans«
- harmless cluster«
- generx«
- functional exercise test«
- fledged vessel lumen«
- fgf-1 treatment«
- fgf-1 protein«
- fgf-1 injection«
- excellent therapeutic target«
- established chemotherapy«
- endothelial cell adhesion«
- efficacy readout«
- earlier protein«
- diverse biological response«
- disruptive interference«
- dii4«
- complete 3d reconstruction«
- collateral artery formation«
- chain receptor tyrosine«
- cell surface fgf«
- bovine capillary endothelial cell«
- beating ischemic heart«
- basic fgf«
- angiopoietins«
- angiogenic therapeutic«
- angiogenic stimulus«
- angiogenic signaling cascade«
- angiogenic research«
- angiogenic protein therapy«
- angiogenic gene therapy«
- angiogenesis response«
- angiogenesis clinical trial«
- agent-2 clinical study«
- agent trial«
- additional human fgf-1 trial«
- ad5fgf4«
- acidic fgf«
- drug«
- wound space/cavity«
- vessel density«
- vessel bilayer«
- tumor expansion«
- therapeutic target«
- substantial shedding«
- stimulating blood vessel growth«
- rich microvasculature«
- promising efficacy«
- potent angiogenic growth factor«
- notch family«
- nitric oxide result«
- mosaic vessel«
- mechanical stimulation«
- key tyrosine«
- interstitial matrix«
- healing disorder«
- form solid«
- endothelial cell junction«
- credible success«
- capillary growth«
- ang1«
- cascade«
- western world«
- fda«
- vessel permeability«
- structured protein«
- stenotic vessel«
- selection agent«
- potent angiogenic factor«
- optimal dos«
- neuroangiogenesis«
- neighboring vessel«
- negative regulatory effect«
- mouse xenograft«
- klagsbrun«
- ischemic cardiovascular disease«
- human myocardium«
- glioblastoma model«
- fgf gene«
- dedicated blood supply«
- beaker blog«
- angiogenic drug«
- afgf«
- abnormal vasculature«
- result«
- vasculogenic mimicry«
- tumstatin«
- treadmill exercise test«
- therapeutic angiogenesis«
- significant therapeutic effect«
- protein growth factor«
- potent mitogen«
- fragile process«
- angiographic«
- angiogenesis foundation«
- recent study«
- vessel structure«
- tumor stem cell«
- sequential presentation«
- relative expression level«
- previous clinical trial«
- other clinician«
- mosaicity«
- antiangiogenic therapy«
- study«
- vegf pathway«
- tumor vessel«
- single cancer cell«
- no«
- specific fragment«
- protein-«
- edge field«
- diverse cell type«
- cellular microenvironment«
- rapid generation time«
- normal blood vessel«
- fibroblast growth factor-2«
- chain peptide«
- arterial vessel«
- human«
- vessel formation«
- tumor blood vessel«
- pharmacokinetic data«
- embryo form«
- collateral vessel«
- angiogenic agent«
- recent animal study«
- potent stimulator«
- nutrient delivery«
- vessel lumen«
- tumor therapy«
- receptor dimerization«
- german trial«
- angiostatin«
- selective targeting«
- application«
- therapeutic gene«
- temporal profile«
- mrna production«
- ischemic insult«
- intramuscular route«
- wet macular degeneration«
- low variation«
- endothelial cell proliferation«
- endostatin«
- adenoviral vector«
- vegfr-2«
- neonatal rat«
- presence«
- cell signal«
- cardiac ischemia«
- active tissue«
- poor blood flow«
- oxygen exchange«
- chemical stimulation«
- disorder«
- vegf receptor«
- several clinical trial«
- physical organization«
- normal physiological process«
- vegf.«
- sheer complexity«
- amount«
- biological signal«
- cell compartment«
- several disease«
- nutrient deprivation«
- stage clinical trial«
- product«
- pmap«
- atherosclerotic disease«
- treatment choice«
- theoretical potential«
- exercise tolerance«
- clinical endpoint«
- limited representation«
- secondary tumor«
- drug approval«
- judah folkman«
- dietary component«
- vital process«
- receptor subtypes«
- gene activation«
- signal transduction cascade«
- myofibroblasts«
- matrix metalloproteinase«
- microvasculature«
- enzyme«
- histological section«
- migration«
- proteolysis map«
- affected tissue«
- therapeutic protein«
- traditional therapy«
- peripheral arterial disease«
- vascular injury«
- hypoxic«
- individual protein«
- neovascularization«
- chronic wound«
- effective integration«
- capillarity«
- chemical«
- peripheral artery disease«
- receptor activation«
- receptor family«
- autophosphorylation«
- threefold increase«
- ideal target«
- single photon emission«
- specific compound«
- exercise«
- specific cell type«
- genomic instability«
- endurance training«
- natural manner«
- chemotherapeutic drug«
- effect«
- fundamental step«
- angiogram«
- plasminogen«
- catenin«
- single agent«
- safety data«
- potential toxicity«
- distant site«
- zone«
- total flow«
- generation time«
- primary endpoint«
- immunogenicity«
- adhesion molecule«
- fashion«
- target tissue«
- single vessel«
- mechanism«
- body«
- receptor protein«
- preclinical study«
- viral vector«
- subsequent growth«
- hypercholesterolemia«
- genetic abnormality«
- morphogenesis«
- neurogenesis«
- germination«
- sprouting«
- recapitulation«
- psychosexual development«
- suppression«
- efflorescence«
- life cycle«
- cultivation«
- psychomotor development«
- flowering«
- rooting«
- leafing«
- cohesion«
- blossoming«
- habit«
- gametogenesis«
- vegetation«
- produce«
- virilization«
- foliation«
- anthesis«
- masculinization«
- culture«
- inflorescence«
- dentition«
- virilisation«
- teratogenesis«
- psychogenesis«
- palingenesis«
- odontiasis«
- myelinization«
- myelinisation«
- masculinisation«
- kenogenesis«
- kainogenesis«
- juvenescence«
- infructescence«
- fructification«
- cytogeny«
- cytogenesis«
- cenogenesis«
- cainogenesis«
- caenogenesis«
- auxesis«
- amelogenesis«
- age«
- apposition«
- teething«
- florescence«
- get«
- spermatogenesis«
- ripening«
- spud«
- biological science«
- stool«
- aging«
- tiller«
- raiser«
- oogenesis«
- biology«
- progress«
- precocious dentition«
- bloom«
- bud«
- agriculturalist«
- feather«
- cultivator«
- blossom«
- ageing«
- advance«
- build«
- acquiring«
- agriculturist«
- spike«
- swell«
- pod«
- starter«
- spring«
- root«
- leaf«
- grower«
- maturement«
- geezerhood«
- flower«
- old age«
- shoot«
- getting«
- twin«
- turn«
- eld«
- years«
- find«
- set«
- stock«
- cut«